Vinet-Jones, Heather and Darr, Kevin F
Submitted to Regenerative Medicine (May 2020)
Non-digested micro-fragmented adipose tissue (MFat™, Lipogems®) was utilized to treat shoulder joint pain and inflammation associated dysfunction in 25 patients with mild (n=12) to moderate (n=13) shoulder osteoarthritis (OA) who have completed follow-ups at 6, 18, and 52 week intervals. All study participants received an injection of autologous MFat™ therapy to affected shoulders. Quantitative analysis of pain and function modalities was performed using the Visual Analog Scale (VAS) and the Disabilities of the Arm, Shoulder, and Hand (DASH) Western Ontario and McMaster Universities Arthritis Index (WOMAC) respectively. Study results demonstrate progressive improvement in pain as well as restoration of function in the shoulder joint in mild to moderate cases of OA for at least one year following Lipogems® MFat™ therapy.